This profile hasn't yet passed our validation checks
Submit your email to push it up the queue
Fresenius Kabi Aktiengesellschaft
Fresenius Kabi Aktiengesellschaft, commonly referred to as Fresenius Kabi, is a global healthcare company headquartered in Bad Homburg, Germany. Founded in 1999, the company has established itself as a leader in the pharmaceutical and medical technology sectors, focusing on lifesaving medicines and technologies. Fresenius Kabi operates in over 100 countries, with significant presence in Europe, North America, and Asia. The company’s core offerings include intravenous (IV) drugs, infusion therapies, and clinical nutrition products, all designed to enhance patient care. Notably, Fresenius Kabi is recognised for its commitment to quality and innovation, which has solidified its position in the market. With a strong emphasis on sustainability and patient safety, Fresenius Kabi continues to achieve notable milestones, contributing significantly to the global healthcare landscape.
DitchCarbon Score
How does Fresenius Kabi Aktiengesellschaft's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Real Estate Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Fresenius Kabi Aktiengesellschaft's score of 38 is higher than 63% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Fresenius Kabi Aktiengesellschaft, headquartered in Germany (DE), currently does not have specific carbon emissions data available for the most recent year. The company is a current subsidiary of Fresenius SE & Co. KGaA, which may influence its climate commitments and emissions reporting. As of now, there are no documented reduction targets or climate pledges from Fresenius Kabi. The absence of specific emissions data and reduction initiatives suggests that the company may be in the early stages of developing its climate strategy or reporting framework. Fresenius Kabi's climate commitments may be informed by the broader sustainability initiatives of its parent company, Fresenius SE & Co. KGaA, which has been active in addressing climate change and may have cascading targets or performance metrics that impact Fresenius Kabi's operations. However, without specific data or targets from Fresenius Kabi itself, it is challenging to provide a detailed overview of its carbon emissions and climate commitments.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|
| Scope 1 | 521,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 1,013,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | - | - | - | - | 0,000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Fresenius Kabi Aktiengesellschaft is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
